Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases. | Cancer Med | 2023 | 37501501 | PubTator, text mining | PubMed |
| Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies. | J Hematol Oncol | 2023 | 37501154 | PubTator, text mining | PubMed |
| Deep immunophenotyping reveals clinically distinct cellular states and ecosystems in large-scale colorectal cancer. | Commun Biol | 2023 | 37500893 | PubTator, text mining | PubMed |
| A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners. | Glycobiology | 2023 | 37498177 | PubTator, text mining | PubMed |
| Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas. | Acta Neuropathol | 2023 | 37495858 | PubTator, text mining | PubMed |
| Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level. | Dis Model Mech | 2023 | 37493341 | PubTator, text mining | PubMed |
| Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context. | Onco Targets Ther | 2023 | 37492075 | PubTator, text mining | PubMed |
| Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers. | Cell Death Dis | 2023 | 37488117 | PubTator, text mining | PubMed |
| Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients. | Front Immunol | 2023 | 37483622 | PubTator, text mining | PubMed |
| Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance. | Commun Biol | 2023 | 37479893 | PubTator, text mining | PubMed |
| Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector. | Nat Commun | 2023 | 37474509 | PubTator, text mining | PubMed |
| Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations. | Discov Oncol | 2023 | 37466782 | PubTator, text mining | PubMed |
| New treatment options in elderly patients with Diffuse Large B-cell Lymphoma. | Front Oncol | 2023 | 37465115 | PubTator, text mining | PubMed |
| T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions. | Front Oncol | 2023 | 37465110 | PubTator, text mining | PubMed |
| Next generation pan-cancer blood proteome profiling using proximity extension assay. | Nat Commun | 2023 | 37463882 | PubTator, text mining | PubMed |
| Targeting MYC-driven lymphoma: lessons learned and future directions. | Cancer Drug Resist | 2023 | 37457123 | PubTator, text mining | PubMed |
| The Evolutionary Scenario of Pediatric Unclassified Primary Antibody Deficiency to Adulthood. | J Clin Med | 2023 | 37445241 | PubTator, text mining | PubMed |
| Pathology and new insights in central nervous system lymphomas. | Curr Opin Oncol | 2023 | 37439536 | PubTator, text mining | PubMed |
| Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors. | Front Immunol | 2023 | 37435085 | PubTator, text mining | PubMed |
| Identification of Potential Novel B-Cell Epitopes of Capsid Protein VP2 in Senecavirus A. | Microbiol Spectr | 2023 | 37428080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=29